Àü±â»ý¸®ÇÐ ±â±â ½ÃÀå º¸°í¼­ : Á¦Ç°, ÀûÀÀÁõ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2025-2033³â)
Electrophysiology Devices Market Report by Product, Indication (Atrial Fibrillation, Supraventricular Tachycardia, Atrioventricular Nodal Re-entry Tachycardia, Wolff-Parkinson-White Syndrome, Bradycardia, and Other), End User, and Region 2025-2033
»óǰÄÚµå : 1800893
¸®¼­Ä¡»ç : IMARC
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 148 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,221,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ® µîÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,628,000
PDF & Excel (5 User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ Copy&Paste°¡ ºÒ°¡´ÉÇÕ´Ï´Ù. Àμâ´Â 5ºÎ±îÁö °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 7,036,000
PDF & Excel (Corporate License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ Copy&Paste°¡ ºÒ°¡´ÉÇÕ´Ï´Ù. Àμâ´Â 5ºÎ±îÁö °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è Àü±â»ý¸®ÇÐ ±â±â ½ÃÀå ±Ô¸ð´Â 2024³â 67¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. IMARC GroupÀº 2033³â±îÁö ½ÃÀå ±Ô¸ð°¡ 129¾ï ´Þ·¯¿¡ ´ÞÇϰí, 2025-2033³â 7.58%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ºÎÁ¤¸Æ »ç·Ê Áõ°¡, ±â¼ú ¹ßÀü, Àúħ½ÀÀû ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÀÇ·áºñ Áõ°¡, ¿Ü·¡ Ä¡·á ȯ°æ È®´ë, À¯¸®ÇÑ »óȯ Á¤Ã¥, Á¶±â Áø´Ü¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ÀÇ·á±â±â¿¡ ÀΰøÁö´É(AI) ÅëÇÕ µîÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

Àü±â»ý¸®ÇÐ ±â±â ½ÃÀå µ¿Çâ :

½ÉÀå ºÎÁ¤¸ÆÀÇ À¯º´·ü Áõ°¡

½É¹æ¼¼µ¿(AF) ¹× ±âŸ ´Ù¾çÇÑ ¾Ç¼º Áúȯ°ú °°Àº ½ÉÀå ºÎÁ¤¸ÆÀÇ À¯º´·ü Áõ°¡°¡ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¾÷°è º¸°í¼­¿¡ µû¸£¸é, ½É¹æ¼¼µ¿(AF)Àº ½ÉÀåÀÇ Àü±âÀû ¶Ç´Â ½ÅÈ£/Ç÷¯ÅÍ ¹®Á¦·Î ¾Ë·ÁÁ® ÀÖÀ¸¸ç, ¹Ì±¹¿¡¼­ ¾à 270¸¸ ¸íÀÌ ¾Î°í ÀÖ´Ù°í ÇÕ´Ï´Ù. ½É¹æ¼¼µ¿Àº ³úÁ¹Áß°ú ½ÉºÎÀüÀÇ °¡Àå ÈçÇÑ ¿øÀÎÀ¸·Î ÀÇ·á¼­ºñ½º¿¡ ´ëÇÑ ºÎ´ãÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±â¼úÀÇ ¹ßÀü°ú °¡Ã³ºÐ ¼Òµæ Áõ°¡·Î ºÎÁ¤¸Æ¿¡ ´ëÇÑ È¯ÀÚµéÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ Á¶±â Áø´Ü ¹× Á¶±â Ä¡·á°¡ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù.

Àü±â »ý¸®ÇÐ ÀåÄ¡ÀÇ ±â¼ú ¹ßÀü

Àü±â »ý¸®ÇÐ ÀåÄ¡ ½ÃÀåÀÇ ¼ºÀåÀº ÁÖ·Î ±Þ¼ÓÇÑ ±â¼ú ¹ßÀü¿¡ ÀÇÇØ µÞ¹ÞħµÇ°í ÀÖ½À´Ï´Ù. 3D ¸ÅÇÎ ½Ã½ºÅÛ ¹× ±âŸ ±â¼ú Çõ½ÅÀ» ÅëÇØ ½ÉÀå Àü¹®ÀÇ´Â ½ÉÀåÀÇ Àü±âÀû Ȱµ¿ÀÇ Æ¯Á¤ ¸ðµ¨À» ¼³°èÇÒ ¼ö ÀÖ°Ô µÇ¾î ºÎÁ¤¸Æ ȯÀÚÀÇ Áø´Ü°ú Ä¡·á¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ä«Å×ÅÍ ÀýÁ¦¼ú ±â¼úÀÇ ¹ßÀüÀº ½Ã¼úÀÇ À§ÇèÀ» ÁÙÀ̰í, ȯÀÚÀÇ È¸º¹ ½Ã°£À» ÃÖ¼ÒÈ­Çϸç, ¼º°ø·üÀ» ³ôÀÌ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó Àü±â »ý¸®Çп¡¼­ ·Îº¿ º¸Á¶ ½Ã½ºÅÛÀÇ »ç¿ëÀº ¼ö¼ú Áß Á¤È®µµ¿Í Á¦¾î¸¦ Çâ»ó½ÃÄÑ ½ÃÀå ¼ºÀåÀ» Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Àúħ½ÀÀû ½Ã¼úÀÇ ¼ºÀå

ÃÖ¼Òħ½À(MI) Àü±â»ý¸®ÇÐÀû ½Ã¼úÀº ȸº¹ ½Ã°£, ÀÔ¿ø ±â°£, ½Ã¼ú À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖ¾î ȯÀÚ Ä¡·á¿¡ Å« ¼ö¿ä¸¦ ºÒ·¯ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ºÎÁ¤¸Æ Ä¡·á¿¡ »ç¿ëµÇ´Â Ä«Å×ÅÍ ÀýÁ¦¼ú°ú °°Àº ½Ã¼úÀº Ç¥ÁØ ¼ö¼úÀÇ ´ë¾ÈÀ¸·Î º¸´Ù ´ú ¿Ü»óÀûÀÎ ´ë¾ÈÀ» Á¦°øÇÕ´Ï´Ù. À̸¦ ÅëÇØ ´õ¿í Á¤È®ÇÑ Áø´ÜÀÌ °¡´ÉÇØÁ® ȯÀÚÀÇ ¼ö¼ú ºñ¿ë°ú ºÎ´ãÀ» ÁÙÀ̸鼭 Ä¡·á °á°ú¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î, À̹Ì¡ ¹× ¸ÅÇÎ ±â¼úÀÇ °³¹ßÀº MI °³ÀÔÀ» ´õ ¹ø°Å·Ó°Ô ¸¸µéÁö ¾Ê°í ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­·Ð

Á¦5Àå ¼¼°èÀÇ Àü±â»ý¸®ÇÐ ±â±â ½ÃÀå

Á¦6Àå ½ÃÀå ºÐ¼® : Á¦Ç°º°

Á¦7Àå ½ÃÀå ºÐ¼® : ÀûÀÀÁõº°

Á¦8Àå ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦10Àå SWOT ºÐ¼®

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå PorterÀÇ Five Forces ºÐ¼®

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global electrophysiology devices market size reached USD 6.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 12.9 Billion by 2033, exhibiting a growth rate (CAGR) of 7.58% during 2025-2033. Rising cardiac arrhythmia cases, technological advancements, growing demand for minimally invasive procedures, increasing healthcare expenditure, expanding outpatient care settings, favorable reimbursement policies, escalating awareness of early diagnosis, and the integration of artificial intelligence (AI) in medical devices are some of the factors driving the market growth.

Electrophysiology Devices Market Trends:

Rising Prevalence of Cardiac Arrhythmias

Increasing prevalence of cardiac arrhythmias such as atrial fibrillation (AF) and various other malignant are driving the market growth. According to the industry reports, atrial fibrillation (AF), known as the electrical or signaling/flutter problem in the heart, is affecting almost 2.7 million people in United States. AF is the most common cause of strokes and heart failure, which is creating a growing burden on health services. In addition, expanding technological advancements and disposable income has boosted awareness about arrhythmias among patients, due to which they prefer early diagnosis and treatment.

Technological Advancements in Electrophysiology Devices

The growth of the electrophysiology devices market is primarily bolstered by the rapid technological advancements. 3D mapping systems and other innovations enable cardiologists to design specified models of the heart's electrical activity, which improves diagnosis and treatment for patients suffering with arrhythmias. Additionally, the improvements in catheter ablation technologies helps reduce procedural risks, while minimizing patient recovery times and increasing success rates. In line with this, the use of robotic-assisted systems in electrophysiology has also improved the precision and control during procedures, which is providing a considerable boost to the market growth.

Growth of Minimally Invasive Procedures

Minimally invasive (MI) electrophysiology procedures can reduce recovery times, hospital stays, and procedural risks, which is why they are witnessing a considerable demand for the treatment of patients. Procedures such as catheter ablation, which are used to treat arrhythmias, provide a less traumatic alternative to the standard surgeries. This further enables an accurate diagnosis and enhances the results of treatment at a reduced cost and strain of surgeries on patients. Apart from this, the development of imaging and mapping technologies, in turn, has made MI interventions less cumbersome, which is facilitating the market growth.

Electrophysiology Devices Market Segmentation:

Breakup by Product:

Diagnostic devices accounts for the majority of the market share

The diagnostic devices segment is driven by the increasing prevalence of cardiovascular diseases, particularly arrhythmias, which require precise diagnosis for effective treatment. Technological advancements, such as improved electrocardiographs (ECGs) and EP mapping systems, are enhancing diagnostic accuracy, leading to wider adoption of these devices. Additionally, the growing awareness of early detection and prevention of heart conditions is boosting demand for diagnostic tools like Holter monitors and insertable cardiac monitors (ICMs). Healthcare providers are increasingly relying on these devices for continuous monitoring and accurate data collection, which improves patient outcomes. The rise in minimally invasive diagnostic procedures, which offer quicker recovery times and reduce the need for hospital stays, is further contributing to the segment's growth.

Breakup by Indication:

Atrial fibrillation (AF) holds the largest share of the industry

The atrial fibrillation (AF) segment is driven by the increasing global prevalence of AF, particularly among aging populations, which is a leading cause of stroke and heart failure. As awareness about AF grows, there is a rising demand for early diagnosis and effective treatment, prompting healthcare providers to invest in advanced electrophysiology devices. Technological advancements in diagnostic tools, such as 3D mapping systems and catheter ablation technologies, have improved the accuracy of AF detection and treatment success rates, boosting adoption. Additionally, the growing preference for minimally invasive procedures, which offer faster recovery times and reduced complications, is further accelerating demand for electrophysiology devices in AF management.

Breakup by End User:

Hospitals represents the leading market segment

The hospital segment is driven by the increasing prevalence of cardiovascular diseases, particularly arrhythmias, which require specialized electrophysiology procedures. Hospitals are equipped with advanced technology, such as 3D mapping and catheter ablation systems, enabling them to offer comprehensive cardiac care. The growing demand for minimally invasive procedures, which are often performed in hospital settings, further fuels this segment. Additionally, hospitals have skilled healthcare professionals capable of handling complex electrophysiology treatments, which boosts patient confidence in seeking care at these facilities. Rising healthcare expenditure, particularly in developed regions, allows hospitals to invest in cutting-edge electrophysiology devices, enhancing their capabilities.

Breakup by Region:

North America leads the market, accounting for the largest electrophysiology devices market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for electrophysiology devices.

As per the electrophysiology devices market dynamics, the North America's regional market is driven by the increasing prevalence of cardiovascular diseases, particularly atrial fibrillation, among the aging population. Advanced healthcare infrastructure and widespread access to cutting-edge medical technologies support the adoption of electrophysiology devices across the region. Rising awareness of early diagnosis and treatment of heart conditions is boosting demand for these devices. Additionally, the growing preference for minimally invasive procedures has increased the use of catheter ablation and other electrophysiology tools. Continuous advancements in medical technology, such as 3D mapping systems and artificial intelligence (AI) integration, enhance the accuracy and outcomes of procedures, making them more attractive to both patients and healthcare providers, which is further driving the electrophysiology devices demand.

Competitive Landscape:

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Electrophysiology Devices Market

6 Market Breakup by Product

7 Market Breakup by Indication

8 Market Breakup by End User

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â